However, regulatory B (Breg) cells, as a newly designated group, appear to prevent T cell differentiation and promote tumor growth via transforming growth factor-β (TGF-β) and/or interleukin-10 (IL-10) release [15]. This evidence concerns the gene TGFB1 and neoplasm.